At the Forefront of Precision Medicine

Precision Health

In 2016, UCLA Health established the Institute for Precision Health. The goal of the Institute for Precision Health is to revolutionize how we improve health and treat disease. The study of our genes, alongside information about our lifestyle and environment, can help predict which treatments might work best for us. It can also warn us if we are susceptible to addictive medications, such as opioids, or tell us if we are at increased risk for certain cancers so we can make changes to prevent them. 

Genomic medicine, a key component of precision health, gives insight into the health or illness of not only ourselves, but those around us. Dr. Daniel Geschwind and Dr. Clara Lajonchere are combining their talents in the Institute for Precision Health and are using their leadership and strategic vision to facilitate the development of platforms for big data integration, clinical diagnostics, and patient bio-banking.